MEK-Inhibitor Associated Retinopathy (MEKAR)

  • Targeted cancer therapies can cause ocular toxicity
  • It is important to distinguish these ocular toxicities from other ocular conditions. For example: central serous chorioretinopathy (CSR)
  • These cases can be observed without the need for intervention (and often continued on life-saving cancer treatment)